<i>Vernonia amygdalina</i>—Induced Growth Arrest and Apoptosis of Breast Cancer (MCF-7) Cells
- 1 Cellomics and Toxicogenomics Research Laboratory, NIH-RCMI Center for Environmental Health, Jackson State University, Jackson, USA
- 2 Laboratory of Cellular Signalling, Phytoceuticals, Cancer Prevention and Therapies; College of Science, Engineering and Technology, Jackson State University, Jackson, USA
- 3 Cellomics and Toxicogenomics Research Laboratory, NIH-RCMI Center for Environmental Health, Jackson State University, Jackson, USA
Abstract
Breast cancer is the second leading cause of cancer-related deaths of women in the United States. Fortunately, the mor tality rate from breast cancer has decreased in recent years due to an increased emphasis on early detection and more effective treatments. Although great advancements have been made in the treatment and control of cancer progression, significant deficiencies and room for improvement remain. The central objective of this research was to further deter mine the in vitro mechanisms of Vernonia amygdalina (VA) leaf extracts as an anticancer candidate for the treatment of breast cancer. To achieve our objective, MCF-7 cells were treated with different concentrations of VA for 24 hand 48 h. Cell viability, live and dead cells were determined by the means of trypan blue exclusion test. Live and dead cells were further evaluated by propidium iodine (PI) assay using the Cellometer Vision. Cell apoptosis was measured by flow cytometry assessment using annexin V/PI kit. Data obtained from the trypan blue test demonstrated that VA treatment reduces cell viability in a concentration- and time-dependent manner. Result of the PI assay showed a gradual increase in the population of necrotic cells (fluorescence positive cells) in VA-treated cells compared to the control cells (fluo rescence negative cells). Treatment of these cancer cells (MCF-7) for 48 h at concentrations ranging from 250 μg/mL to 1000 μg/mL caused early signs of apoptosis resulting from phosphatidylserine externalization as judged by annexin V assay. We observed a strong concentration-response relationship with regard to VA exposure and annexin V/PI positive cells. In summary, our finding demonstrates that VA-induced cytotoxicity and apoptosis in MCF-7 cells involve phos phatidylserine externalization accompanied by secondary necrotic cell death. With previous findings in our laboratory, the data generated in the present study confirms that VA is a valuable botanical therapeutic agent for the treatment of breast cancer.
- J. R. Ainslie, “List of Plants Used in Native Medicine in Nigeria,” Imperial Forestry Institute, Oxford, 1973, p. 42.
- H. M. Burkill, “The Useful Plants of West Tropical Africa,” 2nd Edition, Royal Botanical Gardens, Kew, Vol. 1, 1985.
- E. B. Izevbigie, “Discovery of Water-Soluble Anticancer Agents (Edotides) from a Vegetable Found in Benin City, Nigeria,” Experimental Biology and Medicine, Vol. 228, No. 3, 2003, pp. 293-298.
- A. Tadesse, A. Gebre-Hiwot, K. Asres, M. Djote and D. Frommel, “The in Vitro Activity of Vernonia amygdalina on Leishmania aethiopica,” Ethiopian Medical Journal, Vol. 31, 1993, pp. 183-189.
- A. M. Hamowia and A. M. Saffaf, “Pharmacological Studies on Vernonia amygdalina (Del) and Tithonia Diversifolia (Gray),” Journal of Veterinary Medicine, Vol. 42, No. 2, 1994, pp. 91-97.
- B. A. Iwalokun, “Enhanced Antimalarial Effects of Chloroquine by Aqueous Vernonia amygdalina Leaf Extract in Mice Infected with Chloroquine Resistant and Sensitive. Plasmodium berghei Strains,” African Health Sciences, Vol. 8, No. 1, 2008, pp. 25-35.
- A. Akah and C. I. Okafor, “Hypoglycaemic Effect of Vernonia Amygdalina Del, in Experimental Rabbits,” Planta Medica, Vol. 1, 1992, pp. 6-10.
- C. G. Yedjou, E. Izevbigie and P. B. Tchounwou, “Preclinical Assessment of Vernonia Amygdalina Leaf Extracts as DNA Damaging Anti-Cancer Agent in the Management of Breast Cancer,” International Journal of Environmental Research and Public Health, Vol. 5, No. 5, 2008, pp. 337-341. doi:10.3390/ijerph5050337
- C. B. Howard, J. Stevens, E. B. Izevbigie, A. Walker and O. McDaniel, “Time and Dose-Dependent Modulation of Phase 1 and Phase 2 Gene Expression in Response to Treatment of MCF-7 Cells with a Natural Anti-Cancer Agent,” Cell and Molecular Biology, Vol. 49, No. 7, 2003, pp. 1057-1065.
- C. G. Yedjou, M. A. Saeed, M. Alamgir Hossain, W. Dorsey, H. Yu and P. B. Tchounwou, “Basic Apoptotic and Necrotic Cell Death in Human Liver Carcinoma (HepG(2)) Cells Induced by Synthetic Azamacrocycle,” Environmental Toxicology, 2012, in Press. doi:10.1002/tox.21786
- G. Koopman, C. P. M. Reute-lingsperger, G. A. M. Kuijten, R. M. J. Keehnen, S. T. Pals and M. H. Jr. van Oers, “Annexin-V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis,” Blood, Vol. 84, No. 5, 1994, pp. 1415-1420.
- O. Adaramoye, B. Ogyngbenro, O. Anyaegou and M. Fafunso, “Protective Effects of Extracts of Vernonia Amygdalina, Hisbicus. Sabdaiffa and Vitamin C against Radiation-Induced Liver Damage in Rats,” Journal of Radiation Research, Vol. 49, 2008, pp. 123-131. doi:10.1269/jrr.07062